Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 501–600 of 875
Moldaver, D. M., Bharhani, M. S., Wattie, J. N., Ellis, R., Neighbour, H., Lloyd, C. M., Inman, M. D., & Larché, M. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.56 · Cited by 25
“This may be due to transient induction in Fox p3 expression in activated effector cells in vehicle-treated mice.(57) IL-35 is a recently described member of the IL-12 family of cytokines that has a critical role in the development and suppressive function of Treg.”
BackgroundHuijts, C. M., Schneiders, F. L., García-Vallejo, J. J., Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, H. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402710 · Cited by 24
“We show that the expression of CTLA-4 was induced in iNKT cells upon culture with IL-10 and rapamycin, as seen for FOXP3, similar to the results previously described in nTregs (9).”
BackgroundResultBiomarkers in chronic graft-versus-host disease
Rozmus, J., & Schultz, K. R. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.27 · Cited by 22
“For example, expression of Foxp3 is a normal consequence of CD4+ T-cell activation [93] and IL-2 is responsible for T-cell antigen receptor-activated Foxp3 expression by both CD4+ and CD8+ human T cells [94].”
BackgroundTyagi, R. K., Jacobse, J., Li, J., Allaman, M. M., Otipoby, K. L., Sampson, E. R., Wilson, K. T., & Goettel, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630204 · Cited by 23
“Given that effector CD4 T cells in humans can upregulate FOXP3 upon activation (38, 39), the true identity of these cells is presently unclear.”
BackgroundRegulatory T cells hamper the efficacy of T-cell-engaging bispecific antibody therapy
Casey, M., Lee, C., Kwok, W. Y., Law, S. C., Corvino, D., Gandhi, M. K., Harrison, S. J., & Nakamura, K. (2023) · Haematologica · doi:10.3324/haematol.2023.283758 · Cited by 26
Ma, Y., Zhou, Y.-L., Yue, C., Zhang, G., Deng, L., Xie, G., Xu, W., & Shen, L. (2015) · Journal of Immunology Research · doi:10.1155/2015/547697 · Cited by 24
Lee, S. K., Kim, J. Y., Jang, B. W., Hur, S. E., Na, B.-J., Lee, M., Fukui, A., Gilman‐Sachs, A., & Kwak-Kim, J. Y.-H. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.03.013 · Cited by 22
T regulatory cell therapy in transplantation: stability, localization and functional specialization
MacDonald, K. G., Orban, P. C., & Levings, M. K. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328355aaaf · Cited by 24
“As the function of Tregs is highly dependent on constitutively high expression of FOXP3 [36], many groups have sought to find ways to stabilize its expression.”
BackgroundSelf-citationDiscrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease
Hvas, C. L., Kelsen, J., Agnholt, J. S., Dige, A. K., Christensen, L. A., & Dahlerup, J. F. (2010) · Autoimmunity · doi:10.3109/08916930903509064 · Cited by 22
“Although the use of CD127 or FOXP3 implies misclassification of activated T cells as Tregs [20,21,36], this Figure 5.”
MethodSingh, A. M., Dahlberg, P. E., Burmeister, K. A., Evans, M. D., Gangnon, R. E., Roberg, K. A., Tisler, C. J., DaSilva, D. F., Pappas, T., Salazar, L. E. P., et al. (2013) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-11-1 · Cited by 22
“This finding is consistent with low level Foxp3 being an activation marker in effector T cells [26-31].”
ResultZhao, X., Ye, F., Chen, L., Lü, W., & Xie, X. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01286.x · Cited by 21
Characterization of regulatory T cells in urban newborns
Ly, N. P., Ruiz‐Perez, B., McLoughlin, R. M., Visness, C. M., Wallace, P. K., Cruikshank, W. W., Tzianabos, A. O., O’Connor, G. T., Gold, D. R., & Gern, J. E. (2009) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-7-8 · Cited by 22
“Although, FOXP3 transcription factor plays a critical role in Treg development and function, [29-31] FOXP3 is also expressed by non-regulatory CD4+ effector cells upon activation [37,38] Compared to their mothers, newborns had reduced CD25+ cell function despite having similar proportion of cells expressing FOXP3+.”
FOXP3 protects conventional human T cells from premature restimulation-induced cell death
Voss, K., Lake, C., Luthers, C. R., Lott, N. M., Dorjbal, B., Arjunaraja, S., Bauman, B. M., Soltis, A. R., Sukumar, G., Dalgard, C. L., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0316-z · Cited by 21
Aire and Foxp3 Expression in a Particular Microenvironment for T Cell Differentiation
Hansenne, I., Louis, C., Martens, H., Dorban, G., Charlet-Renard, C., Peterson, P., & Geenen, V. G. (2008) · NeuroImmunoModulation · doi:10.1159/000179665 · Cited by 21
“pers. observations].Another interesting observation was Foxp3 expression by many T cells inside TNC/thymocyte complexes. Since it is very unlikely that all these Foxp3-positive cells will differentiate into nTreg, this expression may in fact precede further intrathymic selection of nTreg. Alternatively, Foxp3 expressi…”
BackgroundDijke, E., Korevaar, S. S., Çalişkan, K., Balk, A. H. M. M., Maat, A. P. W. M., Weimar, W., & Baan, C. C. (2009) · Transplantation · doi:10.1097/tp.0b013e31819ec2fb · Cited by 23
“Effector T cells down-regulate CD127 early in the course of T-cell activation (24, 30).”
BackgroundRegulatory T cells in autologous stem cell transplantation for autoimmune disease
van Wijk, F., Roord, S. T. A., Vastert, S. J., de Kleer, I., Wulffraat, N. M., & Prakken, B. J. (2008) · Autoimmunity · doi:10.1080/08916930802200182 · Cited by 21
“[36] Allan SE, Crome SQ, Crellin NK, et al.”
BackgroundGarg, G., Nikolouli, E., Hardtke‐Wolenski, M., Toker, A., Ohkura, N., Beckstette, M., Miyao, T., Geffers, R., Floess, S., Gerdes, N., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16221 · Cited by 22
“This is due to transient upregulation of Foxp3 expression by conventional T cells upon their activation or due to downregulation of Foxp3 expression in Tregs under certain inflammatory conditions [40, 49].”
BackgroundRole of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis
de Sio, F. R. S., Passerini, L., Restelli, S., Valente, M. M., Pramov, A., Maccari, M. E., Sanvito, F., Roncarolo, M. G., Porteus, M. H., & Bacchetta, R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.015 · Cited by 21
Self-citationPlasticity of Treg cells: Is reprogramming of Treg cells possible in the presence of FOXP3?
Beyer, M., & Schultze, J. L. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.024 · Cited by 22
Harnessing dendritic cells for the induction of transplantation tolerance
Silk, K. M., & Fairchild, P. J. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32832c6a1d · Cited by 21
Elkord, E., Burt, D. J., Drijfhout, J. W., Hawkins, R. E., & Stern, P. L. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0419-8 · Cited by 22
Immunoregulatory actions of melatonin and zinc during chronicTrypanosoma cruziinfection
Brazão, V., Santello, F. H., Filipin, M. D. V., Azevedo, Â. P., Toldo, M. P. A., de Morais, F. R., & Júnior, J. C. D. P. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12207 · Cited by 23
“It is important to emphasize that upon activation all T cells express CD25, an a chain of the high-affinity IL-2 receptor (IL-2R), both regulatory cells and the activated ones [39, 40].”
BackgroundReprogramming of Th1 cells into regulatory T cells through rewiring of the metabolic status
Kanamori, M., Nakatsukasa, H., Ito, M., Chikuma, S., & Yoshimura, A. (2018) · International Immunology · doi:10.1093/intimm/dxy043 · Cited by 22
The Importance of the Transcription Factor Foxp3 in the Development of Primary Immunodeficiencies
Mertowska, P., Mertowski, S., Podgajna, M., & Grywalska, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040947 · Cited by 21
Demethylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Transplant Recipients
Sherston, S., Vogt, K., Schlickeiser, S., Sawitzki, B., Harden, P., & Wood, K. J. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12899 · Cited by 20
“may also be expressed by activated nonregulatory human T cells (16,17).”
BackgroundHuman T Regulatory Cells: On the Way to Cognition
Kaczorowski, M., & Jutel, M. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0217-2 · Cited by 22
Gündüz, E., Teke, H. Ü., Bilge, N. Ş. Y., Cansu, D. Ü., Bal, C., Korkmaz, C., & Gülbaş, Z. (2013) · Rheumatology International · doi:10.1007/s00296-013-2835-8 · Cited by 20
“In contrast to mice, expression of FOXP3 is not entirely restricted to Tregs in humans [9].”
BackgroundSun, L., Yi, S., & O’Connell, P. J. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00571.x · Cited by 20
Yu, Y., Zitzner, J. R., Houlihan, J. L., Herrera, N. D., Xu, L., Miller, J. W., Mathew, J. M., Tambur, A. R., & Luo, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028948 · Cited by 21
“However, unlike in mice, in humans non-regulatory T cells including effector cells can also up-regulate FoxP3 expression transiently upon activation [42,43].”
BackgroundIPEX as a Consequence of Alternatively Spliced FOXP3
Mailer, R. K. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.594375 · Cited by 25
CD8+ regulatory T cells—A distinct T-cell lineage or a transient T-cell phenotype?
Aandahl, E. M., Torgersen, K. M., & Taskén, K. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.291 · Cited by 20
Clinical and diagnostic potential of regulatory T cell markers: From bench to bedside
Haddadi, M. H., & Negahdari, B. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101518 · Cited by 22
Bojanić, I., Worel, N., Pacini, C. P., Stary, G., Piekarska, A., Flinn, A. M., Schell, K. J., Gennery, A. R., Knobler, R., de Lacerda, J. F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1086006 · Cited by 20
Lewis, S. A., Sutherland, A., Soldevila, F., Westernberg, L., Aoki, M., Frazier, A., Maiche, S., Erlewyn‐Lajeunesse, M., Arshad, S. H., Leonard, S. A., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.07.020 · Cited by 21
Dasgupta, G., Chentoufi, A. A., You, S., Falatoonzadeh, P., Urbano, L. A. A., Akhtarmalik, A., Nguyen, K., Ablabutyan, L., Nesburn, A. B., & BenMohamed, L. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6522 · Cited by 18
Role of FOXP3 gene polymorphism in the susceptibility to Tunisian endemic Pemphigus Foliaceus
Jmaa, M. B., Abida, O., Bahloul, E., Toumi, A., Khlif, S., Fakhfakh, R., Elloumi, N., Sellami, K., Masmoudi, A., Turki, H., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.005 · Cited by 19
“considered as a specific marker to distinguish Treg cells from the other T cells subpopulations[10, 11].”
BackgroundAttenuation of canonical NF‐κB signaling maintains function and stability of human Treg
Ziegler, L. S., Gerner, M. C., Schmidt, R. L. J., Trapin, D., Steinberger, P., Pickl, W. F., Sillaber, C., Egger, G., Schwarzinger, I., & Schmetterer, K. G. (2020) · FEBS Journal · doi:10.1111/febs.15361 · Cited by 19
Transcriptional Control of Regulatory T cells
Delacher, M., Schreiber, L., Richards, D. M., Farah, C., Feuerer, M., & Huehn, J. (2014) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2014_373 · Cited by 19
“For example, Foxp3 expression at low levels can be observed in activated Tconv of mice and human origin without conferring a Treg phenotype (Allan et al. 2007; Miyara et al. 2009; Miyao et al. 2012).”
BackgroundSewgobind, V. D. K. D., van der Laan, L. J. W., Kho, M. M. L., Kraaijeveld, R., Korevaar, S. S., Mol, W. M., Weimar, W., & Baan, C. C. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04183.x · Cited by 25
Tissue expression of IL‐17A and FOXP3 in acne vulgaris patients
Farag, A. G. A., Maraee, A. H., Al‐Sharaky, D. R., Elshaib, M. E., Kohla, M. S. M., & Shehata, W. A. (2020) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.13485 · Cited by 18
Conde, E., Casares, N., Mancheño, U., Elizalde, E., Vercher, E., Capozzi, R., Santamaría, E., Rodríguez-Madoz, J. R., Prósper, F., Lasarte, J. J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.08.017 · Cited by 21
“25,26 24,”
Alfaar, A. S., Stürzbecher, L., Diedrichs‐Möhring, M., Lam, M., Roubeix, C., Ritter, J. M., Schumann, K., Annamalai, B., Pompös, I.-M., Rohrer, B., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02620-w · Cited by 19
Oleic acid triggers metabolic rewiring of T cells poising them for T helper 9 differentiation
Reilly, N. A., Sonnet, F., Dekkers, K. F., Kwekkeboom, J. C., Sinke, L., Hilt, S. T., Suleiman, H. M., Hoeksema, M. A., Mei, H., van Zwet, E. W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109496 · Cited by 22
Vascular disease persistence in giant cell arteritis: are stromal cells neglected?
Karabayas, M., Ibrahim, H., Roelofs, A. J., Reynolds, G., Kidder, D., & Bari, C. D. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225270 · Cited by 22
Krustrup, D., Madsen, C. B., Iversen, M., Engelholm, L. H., Ryder, L. P., & Andersen, C. B. (2013) · Transplant Immunology · doi:10.1016/j.trim.2013.08.002 · Cited by 19
Impairment of Circulating CD4+CD25+GARP+Regulatory T Cells in Patients with Acute Coronary Syndrome
Meng, K., Zhang, W., Zhong, Y., Mao, X., Lin, Y., Huang, Y., Lang, M., Peng, Y., Zhu, Z., Liu, Y., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358639 · Cited by 19
Idiopathic CD4+ Lymphocytopenia: Natural History and Prognostic Factors.
Zonios, D. I., Falloon, J., Bennett, J. E., Shaw, P. A., Chaitt, D. G., Polis, M. A., Kovacs, J. A., Davey, R. T., Lane, H. C., Masur, H., et al. (2008) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(08)60017-x · Cited by 18
Interleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cells
Kannappan, V., Butcher, K., Trela, M., Nicholl, I. D., Wang, W., & Attridge, K. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1970-6 · Cited by 19
Candía, E., Reyes, P., Covián, C., Rodriguez, F., Wainstein, N., Morales, J., Mosso, C., Rosemblatt, M. S., & Fierro, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182009 · Cited by 20
Barczyk, A., Pierzchała, W., Caramori, G., Wiaderkiewicz, R., Kaminski, M., Barnes, P. J., & Adcock, I. M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-22 · Cited by 20
“However, recent studies indicate that a subset of CD4Foxp3 cells in humans are not regulatory but effector CD4 cells [39-41].”
BackgroundRojas, J. M., Wang, L., Owen, S., Knight, K., Watmough, S. J., & Clark, R. E. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.09.004 · Cited by 18
“CD25 and FOXP3 can also be expressed on some activated T cells [31], we co-stained patient’s PBMC with CD127 and CD62L to confirm that the populations used for analysis were truly T-reg.”
ResultFoxp3 Is Required Throughout the Life of a Regulatory T Cell
Lopes, J. E., Soper, D. M., & Ziegler, S. F. (2007) · Science s STKE · doi:10.1126/stke.3932007pe36 · Cited by 18
Pikor, L. A., Arivazhagan, S., Mendicino, M., & Sathiamoorthy, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1626085 · Cited by 18
Bernardo, D., Al-Hassi, H. O., Mann, E. R., Tee, D., Murugananthan, A., Peake, S. T. C., Hart, A. L., & Knight, S. C. (2012) · Human Immunology · doi:10.1016/j.humimm.2011.12.017 · Cited by 17
Bjoern, J., Brimnes, M. K., Andersen, M. H., Straten, P. T., & Svane, I. M. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02494.x · Cited by 18
Dar, S. A., Das, S., Ramachandran, V. G., Bhattacharya, S. N., Mustafa, M., Banerjee, B. D., & Verma, P. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2011.642103 · Cited by 19
“However, as: (1) CD25 and FoxP3 expression are concurrently induced upon lymphocyte activation with various stimuli (Allan et al., 2007; Pillai et al., 2007; Wang et al., 2007); (2) human CD4 lymphocytes with the highest CD25 expression levels are regarded to represent T reg (in contrast to CD4 cells with intermediate…”
BackgroundKrustrup, D., Iversen, M., Martinussen, T., & Andersen, C. B. (2014) · Transplant Immunology · doi:10.1016/j.trim.2014.04.007 · Cited by 17
Coutinho, R., Grassi, M. F. R., Korngold, A. B., Olavarria, V. N., Galvão‐Castro, B., & Mascarenhas, R. E. M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-453 · Cited by 21
“However, it has been reported that Forkhead box P3 (FOXP3) protein may be transiently expressed on activated T CD4 cells and its expression does not necessarily convey regulatory function [40,41].”
BackgroundWeinstein, K. N., Domeier, P. P., & Ziegler, S. F. (2024) · International Immunology · doi:10.1093/intimm/dxae049 · Cited by 16
Monitoring regulatory T cells as a prognostic marker in lung transplantation
Khan, M. A., Lau, C. L., & Krupnick, A. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235889 · Cited by 18
Lange, C. M., Tran, T. Y. V., Farnik, H., Jungblut, S., Born, T., Wagner, T. O. F., & Hirche, T. O. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00973.x · Cited by 16
“However, this cannot be established definitely with our experiments as a recent study has shown that Foxp3 can be expressed transiently in Teff as well [29].”
Molecular Regulation ofCellular Immunity by FOXP3
McMurchy, A. N., Nunzio, S. D., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_3 · Cited by 19
Self-citationJafarinia, M., Mehdipour, F., Hosseini, S. V., Ghahramani, L., Hosseinzadeh, M., & Ghaderi, A. A. (2016) · Tumor Biology · doi:10.1007/s13277-016-5345-y · Cited by 16
“It is reported that IL-2 and IFN-γ are suppressed in FoxP3+ Tregs but not in FoxP3+ effector T cells and activated FoxP3+ effector T cells could produce IL-2 and IFN-γ [29, 30] while conventional Tregs produce few amounts of these two cytokines [29].”
BackgroundInfluentialLi, X., Li, D., Huang, X., Zhou, P., Shi, Q., Zhang, B., & Ju, X. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.02.007 · Cited by 19
Expression of IL-7 receptor in human peripheral regulatory T cells
Ciebiada, M., Kasztalska, K., Górska-Ciebiada, M., Barylski, M., & Górski, P. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.31387 · Cited by 16
“is downregulated on all human T cells after activation and, in contrast with the reported re-expression of CD127 on the majority of peripheral memory and effector T cells, Treg CD4CD25Foxp3 cells remain CD127 [11, 12].”
BackgroundResultRegulatory T cells control diabetes without compromising acute anti-viral defense
Jones, C. B., Pagni, P. P., Fousteri, G., Sachithanantham, S., Dave, A., Calvo, T. R., Miller, J. F., & von Herrath, M. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.05.006 · Cited by 16
“(RAG KO) NOD mice, were exTregs, Teff or an outgrowth of Teff from a mixed pool of Teff and exTregs [45,46].”
BackgroundMahalingam, J., Lin, Y., Chiang, J., Su, P., Fang, J., Chu, Y., Huang, C., Chiu, C., & Lin, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0211 · Cited by 18
“Moreover, some complex evidence indicated that Foxp3 expression was observed in not only Treg cells but also in some effector CD4þ T cells, although the latter were transiently expressed (41).”
BackgroundCavatorta, D. J., Erb, H. N., & Felippe, M. J. B. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00308-12 · Cited by 16
“In other studies, activation-induced FOXP3 expression was insufficient to inhibit IFN- production by human effector T cells (IL-4 and IL-10 were not measured) (1, 17).”
BackgroundA sensitive protocol for FOXP3 epigenetic analysis in scarce human samples
Spreafico, R., Rossetti, M., van den Broek, T., Jansen, N. J. G., Zhang, H., Moshref, M., Prakken, B., van Loosdregt, J., van Wijk, F., & Albani, S. (2014) · European Journal of Immunology · doi:10.1002/eji.201444627 · Cited by 15
FOXP3 deficiency, from the mechanisms of the disease to curative strategies
Borna, Š., Meffre, E., & Bacchetta, R. (2023) · Immunological Reviews · doi:10.1111/imr.13289 · Cited by 26
“Unlike in mice, FOXP3 is expressed transiently in conventional T cells after TCR stimulation in humans, 72 CD25 high CD127 low cells, suggesting that these cells might be the FOXP3 mutant Treg cells.”
BackgroundSelf-citationCD137-expressing regulatory T cells in cancer and autoimmune diseases
Lee, K. Y., Mei, Y., Liu, H., & Schwarz, H. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.12.010 · Cited by 15
Comparison of circulating and intratumoral regulatory T cells in patients with renal cell carcinoma
Gati, A., Amal, G., Raja, M., Derouiche, A., Chebil, M., & Amel, B. A. E. (2015) · Tumor Biology · doi:10.1007/s13277-014-3012-8 · Cited by 17
Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells
Dige, A. K., Hvas, C. L., Deleuran, B. W., Kelsen, J., Bendix, M., Dahlerup, J. F., & Agnholt, J. S. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.603157 · Cited by 15
“Studies of FOXP3 induction in T cells have shown that such a high (and not intermediate) FOXP3-expression is necessary for a T cell to exert suppressive function [16,18,26].”
BackgroundMethodInfluentialDistinct characteristics of Tregs of newborns of healthy and allergic mothers
Černý, V., Hrdý, J., Novotná, O., Petrásková, P., Boráková, K., Kolářová, L., & Prokešová, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207998 · Cited by 18
Traitor or warrior–Treg cells sneaking into the lesions of psoriatic arthritis
Liu, Y., Jarjour, W. N., Olsen, N. J., & Zheng, S. G. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108425 · Cited by 15
Teng, C., Li, T., Wang, T., Liao, D.-C., Wen, Y.-H., Wu, T., Wang, J., Wu, H., Shyu, W., Su, I., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80935-5 · Cited by 17
Immunotherapy response modeling by ex-vivo organ culture for lung cancer
Kamer, I., Bab-Dinitz, E., Zadok, O., Ofek, E., Gottfried, T., Daniel‐Meshulam, I., Hout‐Siloni, G., Nun, A. B., Barshack, I., Onn, A., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02828-w · Cited by 16
Weitz, M., Strahm, B., Meerpohl, J. J., Schmidt, M., & Bassler, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009898.pub3 · Cited by 15
Khan, M. A., Moeez, S., & Akhtar, S. (2013) · Europe PMC (PubMed Central) · doi:10.2450/2013.0258-12 · Cited by 17
Clinical Applications of Regulatory T cells in Adoptive Cell Therapies
Marshall, G. P., Cserny, J., Perry, D. J., Yeh, W.-I., Seay, H. R., Elsayed, A. G., Posgai, A. L., & Brusko, T. M. (2018) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2018.042 · Cited by 16
“In human T cells, however, it alone does not define a Treg cell given that Tconv also transiently express intermediate levels of FOXP3 following activation [100].”
BackgroundŞahın, E., & Sahin, M. A. (2018) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000247 · Cited by 16
Mikkelsen, S., Reckling, S. K., Egan, E. A., & Dean, G. A. (2010) · Virology · doi:10.1016/j.virol.2010.04.016 · Cited by 15
“Human Treg cells have been shown to upregulate FOXP3 expression upon TCR stimulation ex vivo (Allan et al., 2007; Tran, Ramsey, and Shevach, 2007).”
T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1)
Achleitner, A., Clark, M. E., & Bienzle, D. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.009 · Cited by 15
Reubsaet, L. L., Meerding, J., Giezeman, R., de Kleer, I., Arets, B. G. M., Prakken, B. J., Beekman, J. M., & van Wijk, F. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.028 · Cited by 15
Gunnlaugsdottir, B., Maggadottir, S. M., Skaftadóttir, I., & Ludviksson, B. R. (2012) · Scandinavian Journal of Immunology · doi:10.1111/sji.12009 · Cited by 14
Therapeutic application of T regulatory cells in composite tissue allotransplantation
Yang, J.-H., & Eun, S. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1322-5 · Cited by 16
“In addition, several studies have confirmed that Tconv cells under inflammatory condition express Foxp3 as well [58, 71, 77].”
BackgroundTreating arthritis by immunomodulation: is there a role for regulatory T cells?
Wehrens, E. J., van Wijk, F., Roord, S. T. A., Albani, S., & Prakken, B. J. (2010) · Rheumatology · doi:10.1093/rheumatology/keq130 · Cited by 17
Hong, J., Li, H., Chen, M., Zang, Y. C. Q., Skinner, S. M., Killian, J. M., & Zhang, J. (2009) · International Immunology · doi:10.1093/intimm/dxp100 · Cited by 14
“It was reported that the transient FOXP3 induced by activation might not mediate suppressive function (44, 47 ).”
BackgroundKim, J., Hope, C. M., Perkins, G. B., Stead, S. O., Scaffidi, J. C., Kette, F. D., Carroll, R. P., Barry, S. C., & Coates, P. T. H. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1223 · Cited by 14
“In particular, almost 100% of Tconvs exhibited FOXP3 expression similar to nTregs under 1:1 aCD3/CD28 beads, while less than 40% of Tconvs expressed FOXP3 under 1:16 a-CD3/CD28 beads or plate-bound a-CD3 and soluble a-CD28.(65) In addition, mock-stimulated Tconvs exhibited”
BackgroundThe immune landscape of the inflamed joint defined by spectral flow cytometry
Attrill, M. H., Shinko, D., Alexiou, V., Kartawinata, M., study, C., Al‐Abadi, E., Alexiou, V., Allen, C., Armon, K., Begum, R., et al. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae071 · Cited by 17
“CD127highHelioslow cluster 14 cells could represent decreased suppressive function of Tregs in active disease [54] or activated conventional CD127high Tconv that have upregulated Foxp3 [59–62] and thus non-Treg contaminants in the Treg Foxp3 gate in PB, which was not seen in the inflamed joint.”
How and when to pick up the best signals from markers associated with T-regulatory cells?
Kivling, A., Nilsson, L. J., & Faresjö, M. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.03.010 · Cited by 13
Pevec, B., Pevec, M. R., Marković, A. S., Batišta, I., Rijavec, M., Šilar, M., Košnik, M., & Korošec, P. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000338289 · Cited by 13
Samuel, E. R., Beloki, L., Newton, K. R., Mackinnon, S., & Lowdell, M. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085911 · Cited by 13
“Studies have also indicated that FoxP3 expression can be induced in human CD4+ effector T cells after activation as a normal consequence of CD4+ T cell activation [42–46] and that IFN-c and IL-2 production are not suppressed in FoxP3+ effector T cells [47,48], thus bringing into doubt its validity as an exclusive mark…”
BackgroundMadondo, M., Tuyaerts, S., Turnbull, B. B., Vanderstraeten, A., Kohrt, H. E. K., Narasimhan, B., Amant, F. C., Quinn, M. A., & Plebanski, M. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-179 · Cited by 18
“Tregs were defined as expressing high levels of CD25 and FoxP3, which we confirmed expressed low levels of CD127, while Teffs were defined as expressing intermediate levels of CD25 (Additional file 2: Figure S1) as per previous studies [20,21].”
BackgroundInfluentialDistinctive Leukocyte Subpopulations According to Organ Type in Cynomolgus Macaques.
Zitsman, J. S., Alonso‐Guallart, P., Ovanez, C., Kato, Y., Rosen, J. F., Weiner, J. I., & Duran‐Struuck, R. (2016) · PubMed Central · Cited by 13
IL-33 improves the suppressive potential of regulatory T cells in patients with type 1 diabetes
Ryba-Stanisławowska, M. E., Buksa, L., Brandt, A., Juhas, U., & Myśliwiec, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.011 · Cited by 13
Wan, J., Huang, F., Hao, S., Hu, W., Liu, C., Zhang, W., Deng, X., Chen, L., Ma, L., & Tao, R. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480415 · Cited by 14
Clark, D. A., Dmetrichuk, J. M., Dhesy‐Thind, S., Crowther, M. A., & Arredondo, J. L. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.05.006 · Cited by 14
Niakan, A., Faghih, Z., Talei, A., & Ghaderi, A. A. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.10.007 · Cited by 13
Zhang, Y., Li, L., Genest, G., Zhao, W., Ke, D., Bartolucci, S., Pavey, N., Al-Aubodah, T.-A., Lejtenyi, D., Torabi, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705615 · Cited by 13
“However, CD25 and CD127 can be transiently modulated on CD4 TEFF cells upon immune activation and FOXP3 can be transiently expressed in TEFF cells upon T cell receptor (TCR) ligation (32, 33).”
Background
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.